The SH3YL1 gene has recently been implicated as a biomarker for nephropathy in type 2 diabetes (Choi et al., 2021), whereas ALKAL2 enables protein tyrosine kinase activity (Woodling et al., 2020). The gene discussed is ALKAL2; the disease is type 2 diabetes mellitus.